BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas JF, Keller M, Pichler WJ, Peiser M, Luch A, Wanner R, Maggi E, Cavani A, Rustemeyer T, Richter A, Thierse HJ, Sallusto F. T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci 2010;67:4171-84. [PMID: 20717835 DOI: 10.1007/s00018-010-0495-3] [Cited by in Crossref: 112] [Cited by in F6Publishing: 113] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Jiao B, Liu S, Yi M, Zhang J, Yang H, Jiang H, Duan H, Niu Y, Shen M, Cao Y, Wang H, Dai Y. Occupational health effect of TCE exposure: Experiment evidence of gene-environment interaction in hypersensitivity reaction. Chemico-Biological Interactions 2022;368:110220. [DOI: 10.1016/j.cbi.2022.110220] [Reference Citation Analysis]
2 Curato C, Aparicio-soto M, Riedel F, Wehl I, Basaran A, Abbas A, Thierse H, Luch A, Siewert K. Frequencies and TCR Repertoires of Human 2,4,6-Trinitrobenzenesulfonic Acid-specific T Cells. Front Toxicol 2022;4:827109. [DOI: 10.3389/ftox.2022.827109] [Reference Citation Analysis]
3 Hultman PA, Pollard KM. Immunotoxicology of metals. Handbook on the Toxicology of Metals 2022. [DOI: 10.1016/b978-0-12-823292-7.00022-x] [Reference Citation Analysis]
4 Aparicio-Soto M, Curato C, Riedel F, Thierse HJ, Luch A, Siewert K. In Vitro Monitoring of Human T Cell Responses to Skin Sensitizing Chemicals-A Systematic Review. Cells 2021;11:83. [PMID: 35011644 DOI: 10.3390/cells11010083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rühl-Muth AC, Maler MD, Esser PR, Martin SF. Feeding of a fat-enriched diet causes the loss of resistance to contact hypersensitivity. Contact Dermatitis 2021. [PMID: 34218443 DOI: 10.1111/cod.13927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bechara R, Feray A, Pallardy M. Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire? Front Immunol 2021;12:653102. [PMID: 34267746 DOI: 10.3389/fimmu.2021.653102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ogese MO, Watkinson J, Lister A, Faulkner L, Gibson A, Hillegas A, Sakatis MZ, Park BK, Naisbitt DJ. Development of an Improved T-cell Assay to Assess the Intrinsic Immunogenicity of Haptenic Compounds. Toxicol Sci 2020;175:266-78. [PMID: 32159798 DOI: 10.1093/toxsci/kfaa034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Chipinda I, Anderson SE, Siegel PD. Laboratory Techniques for Identifying Causes of Allergic Dermatitis. Immunol Allergy Clin North Am 2021;41:423-38. [PMID: 34225898 DOI: 10.1016/j.iac.2021.04.003] [Reference Citation Analysis]
9 Weiß KT, Schreiver I, Siewert K, Luch A, Haslböck B, Berneburg M, Bäumler W. Tattoos - mehr als nur kolorierte Haut? Auf der Suche nach Tattoo-Allergenen. J Dtsch Dermatol Ges 2021;19:657-71. [PMID: 33979044 DOI: 10.1111/ddg.14436_g] [Reference Citation Analysis]
10 Weiß KT, Schreiver I, Siewert K, Luch A, Haslböck B, Berneburg M, Bäumler W. Tattoos - more than just colored skin? Searching for tattoo allergens. J Dtsch Dermatol Ges 2021;19:657-69. [PMID: 33955682 DOI: 10.1111/ddg.14436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ta GH, Weng CF, Leong MK. In silico Prediction of Skin Sensitization: Quo vadis? Front Pharmacol 2021;12:655771. [PMID: 34017255 DOI: 10.3389/fphar.2021.655771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Hammond S, Thomson P, Meng X, Naisbitt D. In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs. Front Immunol 2021;12:630530. [PMID: 33927714 DOI: 10.3389/fimmu.2021.630530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Martín-Serrano Á, Gonzalez-Morena JM, Barbero N, Ariza A, Sánchez Gómez FJ, Pérez-Inestrosa E, Pérez-Sala D, Torres MJ, Montañez MI. Biotin-Labelled Clavulanic Acid to Identify Proteins Target for Haptenation in Serum: Implications in Allergy Studies. Front Pharmacol 2020;11:594755. [PMID: 33442385 DOI: 10.3389/fphar.2020.594755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Basketter DA, Kimber I, Ezendam J. Predictive Tests for Irritants and Allergens: Human, Animal, and In Vitro Tests. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Martin SF, Bonefeld CM. Mechanisms of Irritant and Allergic Contact Dermatitis. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_59] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Naisbitt DJ, Olsson-Brown A, Gibson A, Meng X, Ogese MO, Tailor A, Thomson P. Immune dysregulation increases the incidence of delayed-type drug hypersensitivity reactions. Allergy 2020;75:781-97. [PMID: 31758810 DOI: 10.1111/all.14127] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
17 Andres E. A new prediction model for distinguishing skin sensitisers based on IL-18 release from reconstructed epidermis: enhancing the assessment of a key event in the skin sensitisation adverse outcome pathway. JDC 2020;4:123-137. [DOI: 10.15406/jdc.2020.04.00164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Martin SF, Bonefeld CM. Mechanisms of Irritant and Allergic Contact Dermatitis. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_59-1] [Reference Citation Analysis]
19 Gibbs S, Martin SF, Corsini E, Thierse H. Identification of Contact Allergens by In Vitro Cell Culture-Based Methods. Kanerva’s Occupational Dermatology 2020. [DOI: 10.1007/978-3-319-68617-2_106] [Reference Citation Analysis]
20 Mayorga C, Montañez MI, Jurado-Escobar R, Gil-Ocaña V, Cornejo-García JA. An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions. Curr Pharm Des 2019;25:3813-28. [PMID: 31692430 DOI: 10.2174/1381612825666191105122414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Thierse H, Luch A. Verbraucherschutz und Risikobewertung — allergieauslösende Substanzen in Verbraucherprodukten. Allergo J 2019;28:22-41. [DOI: 10.1007/s15007-019-1901-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Thierse H, Luch A. Consumer protection and risk assessment: sensitising substances in consumer products. Allergo J Int 2019;28:167-82. [DOI: 10.1007/s40629-019-0093-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Mayorga C, Muñoz-cano R, Rodríguez-nogales A, Fernandez-santamaría R, Fernandez TD. New Insights of Biomarkers in IgE and Non-IgE-Mediated Drug Hypersensitivity. Curr Treat Options Allergy 2019;6:42-55. [DOI: 10.1007/s40521-019-0201-0] [Reference Citation Analysis]
24 Basketter DA, Kimber I, Ezendam J. Predictive Tests for Irritants and Allergens: Human, Animal, and In Vitro Tests. Contact Dermatitis 2019. [DOI: 10.1007/978-3-319-72451-5_13-1] [Reference Citation Analysis]
25 Sajid M, Agrewala JN. Low prevalence of anti-xenobiotic antibodies among the occupationally exposed individuals is associated with a high risk of cancer. Cancer Med 2019;8:246-60. [PMID: 30575301 DOI: 10.1002/cam4.1773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Sharma A, Saito Y, Hung SI, Naisbitt D, Uetrecht J, Bussiere J. The skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash. J Immunotoxicol 2019;16:1-12. [PMID: 30318948 DOI: 10.1080/1547691X.2018.1514444] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
27 Martin SF, Rustemeyer T, Thyssen JP. Recent advances in understanding and managing contact dermatitis. F1000Res 2018;7:F1000 Faculty Rev-810. [PMID: 29983912 DOI: 10.12688/f1000research.13499.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
28 Huppert C, Paris C, Langonné I, Muller S, Mathiot J, Abdessadeq H, Gagnaire F, Battais F, Sponne I. Activation of T cells by dendritic cells exposed to a reference sensitizer: Towards a promising model to assess the allergenic potential of chemicals. Contact Dermatitis 2018;79:67-75. [PMID: 29635784 DOI: 10.1111/cod.12991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Sullivan A, Watkinson J, Waddington J, Park BK, Naisbitt DJ. Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions. Expert Opinion on Drug Metabolism & Toxicology 2018;14:261-74. [DOI: 10.1080/17425255.2018.1441285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
30 Karlsson I, Samuelsson K, Simonsson C, Stenfeldt AL, Nilsson U, Ilag LL, Jonsson C, Karlberg AT. The Fate of a Hapten - From the Skin to Modification of Macrophage Migration Inhibitory Factor (MIF) in Lymph Nodes. Sci Rep 2018;8:2895. [PMID: 29440696 DOI: 10.1038/s41598-018-21327-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
31 Corsini E, Casula M, Tragni E, Galbiati V, Pallardy M. Tools to investigate and avoid drug-hypersensitivity in drug development. Expert Opin Drug Discov 2018;13:425-33. [PMID: 29405076 DOI: 10.1080/17460441.2018.1437141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Frombach J, Sonnenburg A, Krapohl B, Zuberbier T, Peiser M, Stahlmann R, Schreiner M. Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly. Arch Toxicol 2018;92:1495-505. [DOI: 10.1007/s00204-018-2164-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
33 Gibbs S, Martin SF, Corsini E, Thierse H. Identification of Contact Allergens by In Vitro Cell Culture-Based Methods. Kanerva’s Occupational Dermatology 2018. [DOI: 10.1007/978-3-319-40221-5_106-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Martin SF. Contact Allergy. Environment and Skin 2018. [DOI: 10.1007/978-3-319-43102-4_5] [Reference Citation Analysis]
35 Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, Park BK, Naisbitt DJ. β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. Journal of Allergy and Clinical Immunology 2018;141:235-249.e8. [DOI: 10.1016/j.jaci.2017.01.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
36 Musette P, Janela B. New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology. Front Med (Lausanne) 2017;4:179. [PMID: 29255708 DOI: 10.3389/fmed.2017.00179] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
37 Pérez-Ruíz R, Lence E, Andreu I, Limones-Herrero D, González-Bello C, Miranda MA, Jiménez MC. A New Pathway for Protein Haptenation by β-Lactams. Chemistry 2017;23:13986-94. [PMID: 28791745 DOI: 10.1002/chem.201702643] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
38 Dusinska M, Tulinska J, El Yamani N, Kuricova M, Liskova A, Rollerova E, Rundén-Pran E, Smolkova B. Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing? Food Chem Toxicol 2017;109:797-811. [PMID: 28847762 DOI: 10.1016/j.fct.2017.08.030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 12.7] [Reference Citation Analysis]
39 Vocanson M, Mutez V, Esser PR, Bachtanian E, Cluzel M, Nosbaum A, Martin SF, Nicolas J. Contact hypersensitivity: T-cell based assay. Current Opinion in Toxicology 2017;5:39-45. [DOI: 10.1016/j.cotox.2017.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Galbiati V. In vitro testing of drug-induced systemic hypersensitivity: Just a burden or an opportunity? Current Opinion in Toxicology 2017;5:33-38. [DOI: 10.1016/j.cotox.2017.07.006] [Reference Citation Analysis]
41 Höper T, Mussotter F, Haase A, Luch A, Tralau T. Application of proteomics in the elucidation of chemical-mediated allergic contact dermatitis. Toxicol Res (Camb) 2017;6:595-610. [PMID: 30090528 DOI: 10.1039/c7tx00058h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
42 Koppes SA, Engebretsen KA, Agner T, Angelova-fischer I, Berents T, Brandner J, Brans R, Clausen M, Hummler E, Jakasa I, Jurakić-tončic R, John SM, Khnykin D, Molin S, Holm JO, Suomela S, Thierse H, Kezic S, Martin SF, Thyssen JP. Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis. Contact Dermatitis 2017;77:1-16. [DOI: 10.1111/cod.12789] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
43 Pallardy M, Bechara R. Chemical or Drug Hypersensitivity: Is the Immune System Clearing the Danger? Toxicological Sciences 2017;158:14-22. [DOI: 10.1093/toxsci/kfx084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
44 Rehberger K, Werner I, Hitzfeld B, Segner H, Baumann L. 20 Years of fish immunotoxicology - what we know and where we are. Crit Rev Toxicol 2017;47:509-35. [PMID: 28425344 DOI: 10.1080/10408444.2017.1288024] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]
45 Vukmanović S, Sadrieh N. Skin sensitizers in cosmetics and beyond: potential multiple mechanisms of action and importance of T-cell assays for in vitro screening. Critical Reviews in Toxicology 2017;47:422-39. [DOI: 10.1080/10408444.2017.1288025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
46 Jakob A, Mussotter F, Ohnesorge S, Dietz L, Pardo J, Haidl ID, Thierse HJ. Immunoproteomic identification and characterization of Ni2+-regulated proteins implicates Ni2+ in the induction of monocyte cell death. Cell Death Dis 2017;8:e2684. [PMID: 28300831 DOI: 10.1038/cddis.2017.112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
47 Martin SF, Jakob T. Contact Dermatitis. Clinical and Basic Immunodermatology 2017. [DOI: 10.1007/978-3-319-29785-9_23] [Reference Citation Analysis]
48 Esser PR, Martin SF. The Human T Cell Priming Assay (hTCPA). Alternatives for Dermal Toxicity Testing 2017. [DOI: 10.1007/978-3-319-50353-0_31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Gan J, Zhang H, Humphreys WG. Drug–Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization. Chem Res Toxicol 2016;29:2040-57. [DOI: 10.1021/acs.chemrestox.6b00274] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
50 Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ. New Approaches to Investigate Drug-Induced Hypersensitivity. Chem Res Toxicol 2017;30:239-59. [DOI: 10.1021/acs.chemrestox.6b00333] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
51 Faulkner L, Gibson A, Sullivan A, Tailor A, Usui T, Alfirevic A, Pirmohamed M, Naisbitt DJ, Kevin Park B. Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity. Toxicol Sci 2016;154:416-29. [DOI: 10.1093/toxsci/kfw177] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
52 Ezendam J, Braakhuis HM, Vandebriel RJ. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies. Arch Toxicol 2016;90:2861-83. [PMID: 27629427 DOI: 10.1007/s00204-016-1842-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 10.7] [Reference Citation Analysis]
53 Andres E, Barry M, Hundt A, Dini C, Corsini E, Gibbs S, Roggen EL, Ferret PJ. Preliminary performance data of the RHE/IL-18 assay performed on SkinEthic RHE for the identification of contact sensitizers. Int J Cosmet Sci 2017;39:121-32. [PMID: 27455141 DOI: 10.1111/ics.12355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
54 Mayorga C, Perez-inestrosa E, Molina N, Montañez MI. Development of nanostructures in the diagnosis of drug hypersensitivity reactions. Current Opinion in Allergy & Clinical Immunology 2016;16:300-7. [DOI: 10.1097/aci.0000000000000282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
55 Galbiati V, Papale A, Kummer E, Corsini E. In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells. Front Pharmacol 2016;7:204. [PMID: 27462271 DOI: 10.3389/fphar.2016.00204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
56 Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C, Rothenberg ME, Terreehorst I, Muraro A, Lucendo AJ, Schoepfer A, Straumann A, Simon HU. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy 2016;71:611-20. [PMID: 26799684 DOI: 10.1111/all.12846] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
57 Gaspari AA, Katz SI, Martin SF. Contact Hypersensitivity. Current Protocols in Immunology 2016;113. [DOI: 10.1002/0471142735.im0402s113] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
58 Martin S. Mechanistic Understanding of Contact Allergy. Cosmetics 2016;3:8. [DOI: 10.3390/cosmetics3010008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
59 Martin SF. Novel concepts of immune responses to chemicals in allergic contact dermatitis. Allergo J 2016;25:17-21. [DOI: 10.1007/s15007-016-1014-0] [Reference Citation Analysis]
60 Martin SF. Novel concepts of immune responses to chemicals in allergic contact dermatitis. Allergo J Int 2016;25:1-5. [DOI: 10.1007/s40629-016-0091-7] [Reference Citation Analysis]
61 Gibson A, Kim S, Faulkner L, Evely J, Pirmohamed M, Park KB, Naisbitt DJ. In Vitro Priming of Naı̈ve T-cells with p -Phenylenediamine and Bandrowski’s Base. Chem Res Toxicol 2015;28:2069-77. [DOI: 10.1021/acs.chemrestox.5b00294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
62 Kim SH, Naisbitt DJ. Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury. Allergy Asthma Immunol Res. 2016;8:3-11. [PMID: 26540496 DOI: 10.4168/aair.2016.8.1.3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
63 Naisbitt DJ, Nattrass RG, Ogese MO. In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs. Immunol Allergy Clin North Am 2014;34:691-705, x. [PMID: 25017686 DOI: 10.1016/j.iac.2014.04.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
64 Popple A, Williams J, Maxwell G, Gellatly N, Dearman RJ, Kimber I. The lymphocyte transformation test in allergic contact dermatitis: New opportunities. J Immunotoxicol. 2016;13:84-91. [PMID: 25655136 DOI: 10.3109/1547691x.2015.1008656] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
65 Hultman P, Michael Pollard K. Immunotoxicology of Metals. Handbook on the Toxicology of Metals 2015. [DOI: 10.1016/b978-0-444-59453-2.00019-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Sullivan A, Gibson A, Park BK, Naisbitt DJ. Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions? Expert Opinion on Drug Metabolism & Toxicology 2014;11:357-68. [DOI: 10.1517/17425255.2015.992780] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
67 Stiefel C, Schwack W. Photoprotection in changing times - UV filter efficacy and safety, sensitization processes and regulatory aspects. Int J Cosmet Sci 2015;37:2-30. [DOI: 10.1111/ics.12165] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
68 Martin SF. New concepts in cutaneous allergy. Contact Dermatitis 2015;72:2-10. [DOI: 10.1111/cod.12311] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
69 Gonçalo M, Martins J, Silva A, Neves B, Figueiredo A, Cruz T, Lopes C. Systemic drugs inducing non-immediate cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells. J Appl Toxicol 2015;35:398-406. [PMID: 25091725 DOI: 10.1002/jat.3033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
70 Martin SF, Esser PR. Chemical Allergen-Induced Skin Cell Activation. Molecular Immunotoxicology 2014. [DOI: 10.1002/9783527676965.ch5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 van der Veen JW, Soeteman-hernández LG, Ezendam J, Stierum R, Kuper FC, van Loveren H. Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: Analysis of existing data. Critical Reviews in Toxicology 2014;44:590-9. [DOI: 10.3109/10408444.2014.925425] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
72 van der Veen JW, Rorije E, Emter R, Natsch A, van Loveren H, Ezendam J. Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals. Regul Toxicol Pharmacol 2014;69:371-9. [PMID: 24813372 DOI: 10.1016/j.yrtph.2014.04.018] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 7.7] [Reference Citation Analysis]
73 Ladics GS, Fry J, Goodman R, Herouet-Guicheney C, Hoffmann-Sommergruber K, Madsen CB, Penninks A, Pomés A, Roggen EL, Smit J, Wal JM. Allergic sensitization: screening methods. Clin Transl Allergy 2014;4:13. [PMID: 24739743 DOI: 10.1186/2045-7022-4-13] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
74 Corsini E, Papale A, Galbiati V, Roggen E. Safety Evaluation of Cosmetic Ingredients: In Vitro Opportunities for the Identification of Contact Allergens. Cosmetics 2014;1:61-74. [DOI: 10.3390/cosmetics1010061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
75 Boverhof DR, Ladics G, Luebke B, Botham J, Corsini E, Evans E, Germolec D, Holsapple M, Loveless SE, Lu H, van der Laan JW, White KL, Yang Y. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: A workshop summary. Regulatory Toxicology and Pharmacology 2014;68:96-107. [DOI: 10.1016/j.yrtph.2013.11.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
76 Esser PR, Kimber I, Martin SF. Correlation of contact sensitizer potency with T cell frequency and TCR repertoire diversity. Exp Suppl 2014;104:101-14. [PMID: 24214621 DOI: 10.1007/978-3-0348-0726-5_8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
77 Vocanson M, Nicolas J, Basketter D. In vitro approaches to the identification and characterization of skin sensitizers. Expert Review of Dermatology 2014;8:395-405. [DOI: 10.1586/17469872.2013.814882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
78 Martin SF, Schmucker SS, Richter A. Tools and methods for identification and analysis of rare antigen-specific T lymphocytes. Exp Suppl 2014;104:73-88. [PMID: 24214619 DOI: 10.1007/978-3-0348-0726-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Weltzien HU, Martin SF, Nicolas J. T Cell Responses to Contact Allergens. T Lymphocytes as Tools in Diagnostics and Immunotoxicology 2014. [DOI: 10.1007/978-3-0348-0726-5_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
80 Vocanson M, Achachi A, Mutez V, Cluzel-Tailhardat M, Varlet BL, Rozières A, Fournier P, Nicolas JF. Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells. Exp Suppl 2014;104:89-100. [PMID: 24214620 DOI: 10.1007/978-3-0348-0726-5_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
81 Earnshaw CJ, Pecaric-Petkovic T, Park BK, Naisbitt DJ. T cell responses to drugs and drug metabolites. Exp Suppl 2014;104:137-63. [PMID: 24214623 DOI: 10.1007/978-3-0348-0726-5_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
82 Alloul-ramdhani M, Tensen CP, El Ghalbzouri A. Chemical Sensitization. Toxicogenomics-Based Cellular Models 2014. [DOI: 10.1016/b978-0-12-397862-2.00005-x] [Reference Citation Analysis]
83 Roggen EL, Corsini E, van Loveren H, Luebke R. Immunotoxicity Testing. Toxicogenomics-Based Cellular Models 2014. [DOI: 10.1016/b978-0-12-397862-2.00004-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Gibbs S, Corsini E, Spiekstra SW, Galbiati V, Fuchs HW, Degeorge G, Troese M, Hayden P, Deng W, Roggen E. An epidermal equivalent assay for identification and ranking potency of contact sensitizers. Toxicology and Applied Pharmacology 2013;272:529-41. [DOI: 10.1016/j.taap.2013.07.003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 8.3] [Reference Citation Analysis]
85 Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gómez-Lechón MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013;87:1315-530. [PMID: 23974980 DOI: 10.1007/s00204-013-1078-5] [Cited by in Crossref: 853] [Cited by in F6Publishing: 687] [Article Influence: 85.3] [Reference Citation Analysis]
86 Nandy A, Kar S, Roy K. Development of classification- and regression-based QSAR models and in silico screening of skin sensitisation potential of diverse organic chemicals. Molecular Simulation 2013;40:261-74. [DOI: 10.1080/08927022.2013.801076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
87 Richter A, Schmucker SS, Esser PR, Traska V, Weber V, Dietz L, Thierse H, Pennino D, Cavani A, Martin SF. Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC – IFN-γ and TNF-α readout. Toxicology in Vitro 2013;27:1180-5. [DOI: 10.1016/j.tiv.2012.08.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
88 Gibbs S, Spiekstra S, Corsini E, Mcleod J, Reinders J. Dendritic cell migration assay: A potential prediction model for identification of contact allergens. Toxicology in Vitro 2013;27:1170-9. [DOI: 10.1016/j.tiv.2012.05.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
89 Dietz L, Kinzebach S, Ohnesorge S, Franke B, Goette I, Koenig-gressel D, Thierse H. Proteomic allergen–peptide/protein interaction assay for the identification of human skin sensitizers. Toxicology in Vitro 2013;27:1157-62. [DOI: 10.1016/j.tiv.2012.08.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
90 Roggen EL. Application of the acquired knowledge and implementation of the Sens-it-iv toolbox for identification and classification of skin and respiratory sensitizers. Toxicology in Vitro 2013;27:1122-6. [DOI: 10.1016/j.tiv.2012.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
91 Uetrecht J, Naisbitt DJ. Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev. 2013;65:779-808. [PMID: 23476052 DOI: 10.1124/pr.113.007450] [Cited by in Crossref: 208] [Cited by in F6Publishing: 215] [Article Influence: 20.8] [Reference Citation Analysis]
92 Jeong YH, An S, Shin K, Lee TR. Peptide reactivity assay using spectrophotometric method for high-throughput screening of skin sensitization potential of chemical haptens. Toxicology in Vitro 2013;27:264-71. [DOI: 10.1016/j.tiv.2012.08.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
93 Camous X, Calbo S, Picard D, Musette P. Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis. Current Opinion in Immunology 2012;24:730-5. [DOI: 10.1016/j.coi.2012.07.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
94 Martin SF. Contact dermatitis: from pathomechanisms to immunotoxicology. Exp Dermatol 2012;21:382-9. [PMID: 22509837 DOI: 10.1111/j.1600-0625.2012.01471.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
95 Martin SF. Allergic contact dermatitis: xenoinflammation of the skin. Curr Opin Immunol. 2012;24:720-729. [PMID: 22980498 DOI: 10.1016/j.coi.2012.08.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
96 Esser PR, Wölfle U, Dürr C, von Loewenich FD, Schempp CM, Freudenberg MA, Jakob T, Martin SF. Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS One 2012;7:e41340. [PMID: 22848468 DOI: 10.1371/journal.pone.0041340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Jahn S, Faber H, Zazzeroni R, Karst U. Electrochemistry/liquid chromatography/mass spectrometry to demonstrate irreversible binding of the skin allergen p-phenylenediamine to proteins. Rapid Commun Mass Spectrom 2012;26:1415-25. [PMID: 22592985 DOI: 10.1002/rcm.6247] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
98 Moggs J, Moulin P, Pognan F, Brees D, Leonard M, Busch S, Cordier A, Heard DJ, Kammüller M, Merz M, Bouchard P, Chibout S. Investigative safety science as a competitive advantage for Pharma. Expert Opinion on Drug Metabolism & Toxicology 2012;8:1071-82. [DOI: 10.1517/17425255.2012.693914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
99 Teunis M, Corsini E, Smits M, Madsen CB, Eltze T, Ezendam J, Galbiati V, Gremmer E, Krul C, Landin A, Landsiedel R, Pieters R, Rasmussen TF, Reinders J, Roggen E, Spiekstra S, Gibbs S. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 2013;27:1135-50. [PMID: 22728231 DOI: 10.1016/j.tiv.2012.06.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
100 Mehling A, Eriksson T, Eltze T, Kolle S, Ramirez T, Teubner W, van Ravenzwaay B, Landsiedel R. Non-animal test methods for predicting skin sensitization potentials. Arch Toxicol 2012;86:1273-95. [PMID: 22707154 DOI: 10.1007/s00204-012-0867-6] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 6.2] [Reference Citation Analysis]
101 Calbo S. Severe drug eruptions revisited. Immunol Res 2012;53:162-7. [DOI: 10.1007/s12026-012-8271-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Goebel C, Aeby P, Ade N, Alépée N, Aptula A, Araki D, Dufour E, Gilmour N, Hibatallah J, Keller D, Kern P, Kirst A, Marrec-Fairley M, Maxwell G, Rowland J, Safford B, Schellauf F, Schepky A, Seaman C, Teichert T, Tessier N, Teissier S, Weltzien HU, Winkler P, Scheel J. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation. Regul Toxicol Pharmacol 2012;63:40-52. [PMID: 22374415 DOI: 10.1016/j.yrtph.2012.02.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
103 Gibbs S, Martin SF, Corsini E, Thierse H. Identification of Contact Allergens by In Vitro Cell Culture–Based Methods. Kanerva's Occupational Dermatology 2012. [DOI: 10.1007/978-3-642-02035-3_106] [Reference Citation Analysis]
104 Esser PR, Wölfle U, Dürr C, von Loewenich FD, Schempp CM, Freudenberg MA, Jakob T, Martin SF. Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS One 2012;7:e41340. [PMID: 22848468 DOI: 10.1371/journal.pone.0041340] [Cited by in Crossref: 139] [Cited by in F6Publishing: 140] [Article Influence: 12.6] [Reference Citation Analysis]
105 Kimber I, Maxwell G, Gilmour N, Dearman RJ, Friedmann PS, Martin SF. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency. Toxicology 2012;291:18-24. [PMID: 22120538 DOI: 10.1016/j.tox.2011.11.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
106 Luebke R. Immunotoxicant Screening and Prioritization in the Twenty-first Century. Toxicol Pathol 2011;40:294-9. [DOI: 10.1177/0192623311427572] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
107 Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 2012;69:763-781. [PMID: 21997384 DOI: 10.1007/s00018-011-0846-8] [Cited by in Crossref: 229] [Cited by in F6Publishing: 236] [Article Influence: 19.1] [Reference Citation Analysis]
108 Martin S. Immunologie der Kontaktallergie. Hautarzt 2011;62:739-43. [DOI: 10.1007/s00105-011-2184-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
109 Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg MA, Schmidt M, Goebeler M. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 2011;66:1152-63. [PMID: 21599706 DOI: 10.1111/j.1398-9995.2011.02652.x] [Cited by in Crossref: 215] [Cited by in F6Publishing: 221] [Article Influence: 17.9] [Reference Citation Analysis]
110 Sharma NS, Jindal R, Mitra B, Lee S, Li L, Maguire TJ, Schloss R, Yarmush ML. Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis. Cell Mol Bioeng 2012;5:52-72. [PMID: 24741377 DOI: 10.1007/s12195-011-0189-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
111 Shin Y, Song K, Seo M, Kim S, Park J, Kim D, Park K, Hur C, Cha J, Seo Y. In vitro Biocompatibility Evaluation of Biomaterial-elution Using Inflammatory Cell Lines. KSBB Journal 2011;26:248-254. [DOI: 10.7841/ksbbj.2011.26.3.248] [Reference Citation Analysis]
112 Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, Andersen KE, Angers-Loustau A, Aptula A, Bal-Price A, Benfenati E, Bernauer U, Bessems J, Bois FY, Boobis A, Brandon E, Bremer S, Broschard T, Casati S, Coecke S, Corvi R, Cronin M, Daston G, Dekant W, Felter S, Grignard E, Gundert-Remy U, Heinonen T, Kimber I, Kleinjans J, Komulainen H, Kreiling R, Kreysa J, Leite SB, Loizou G, Maxwell G, Mazzatorta P, Munn S, Pfuhler S, Phrakonkham P, Piersma A, Poth A, Prieto P, Repetto G, Rogiers V, Schoeters G, Schwarz M, Serafimova R, Tähti H, Testai E, van Delft J, van Loveren H, Vinken M, Worth A, Zaldivar JM. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 2011;85:367-485. [PMID: 21533817 DOI: 10.1007/s00204-011-0693-2] [Cited by in Crossref: 392] [Cited by in F6Publishing: 400] [Article Influence: 32.7] [Reference Citation Analysis]